Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation

Amir Hashemi,1 Masoumeh Ezati,2 Javad Mohammadnejad,3 Behzad Houshmand,4 Shahab Faghihi5 1Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 2Tissue Engineering and Biomaterials Research Center, National Institute of Genet...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hashemi A, Ezati M, Mohammadnejad J, Houshmand B, Faghihi S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/c1a348c3c616449e98713e4d19817aee
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c1a348c3c616449e98713e4d19817aee
record_format dspace
spelling oai:doaj.org-article:c1a348c3c616449e98713e4d19817aee2021-12-02T11:55:08ZChitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation1178-2013https://doaj.org/article/c1a348c3c616449e98713e4d19817aee2020-06-01T00:00:00Zhttps://www.dovepress.com/chitosan-coating-of-tio2-nanotube-arrays-for-improved-metformin-releas-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Amir Hashemi,1 Masoumeh Ezati,2 Javad Mohammadnejad,3 Behzad Houshmand,4 Shahab Faghihi5 1Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 2Tissue Engineering and Biomaterials Research Center, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran 14965/161, Iran; 3Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 4Department of Periodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran; 5Tissue Engineering and Biomaterials Research Center, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran 14965/161, IranCorrespondence: Javad Mohammadnejad; Shahab Faghihi Tel +9821 8609-3078Tel/ Fax +98 21 44787386Fax +98(21)88497324Email mohamadnejad@ut.ac.ir; sfaghihi@nigeb.ac.irBackground: Ineffective integration has been recognized as one of the major causes of early orthopedic failure of titanium-based implants. One strategy to address this problem is to develop modified titanium surfaces that promote osteoblast differentiation. This study explored titanium surfaces modified with TiO2 nanotubes (TiO2 NTs) capable of localized drug delivery into bone and enhanced osteoblast cell differentiation.Materials and Methods: Briefly, TiO2 NTs were subjected to anodic oxidation and loaded with Metformin, a widely used diabetes drug. To create surfaces with sustainable drug-eluting characteristics, TiO2 NTs were spin coated with a thin layer of chitosan. The surfaces were characterized via scanning electron microscopy, atomic force microscopy, and contact angle measurements. The surfaces were then exposed to mesenchymal bone marrow stem cells (MSCs) to evaluate cell adhesion, growth, differentiation, and morphology on the modified surfaces.Results: A noticeable increase in drug release time (3 days vs 20 days) and a decrease in burst release characteristics (85% to 7%) was observed in coated samples as compared to uncoated samples, respectively. Chitosan-coated TiO2 NTs exhibited a considerable enhancement in cell adhesion, proliferation, and genetic expression of type I collagen, and alkaline phosphatase activity as compared to uncoated TiO2 NTs.Conclusion: TiO2 NT surfaces with a chitosan coating are capable of delivering Metformin to a bone site over a sustained period of time with the potential to enhance MSCs cell attachment, proliferation, and differentiation.Keywords: titania nanotubes, titanium, osteogenic differentiation, anodization, mesenchymal bone marrow stem cells, MSCsHashemi AEzati MMohammadnejad JHoushmand BFaghihi SDove Medical Pressarticletitania nanotubestitaniumosteogenic differentiationanodizationmesenchymal bone marrow stem cells (mscs)Medicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 4471-4481 (2020)
institution DOAJ
collection DOAJ
language EN
topic titania nanotubes
titanium
osteogenic differentiation
anodization
mesenchymal bone marrow stem cells (mscs)
Medicine (General)
R5-920
spellingShingle titania nanotubes
titanium
osteogenic differentiation
anodization
mesenchymal bone marrow stem cells (mscs)
Medicine (General)
R5-920
Hashemi A
Ezati M
Mohammadnejad J
Houshmand B
Faghihi S
Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation
description Amir Hashemi,1 Masoumeh Ezati,2 Javad Mohammadnejad,3 Behzad Houshmand,4 Shahab Faghihi5 1Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 2Tissue Engineering and Biomaterials Research Center, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran 14965/161, Iran; 3Department of Life Science Engineering, Faculty of New Sciences and Technologies, University of Tehran, Tehran 14395-1561, Iran; 4Department of Periodontics, School of Dentistry, Shahid Beheshti University of Medical Sciences, Tehran 19857-17443, Iran; 5Tissue Engineering and Biomaterials Research Center, National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran 14965/161, IranCorrespondence: Javad Mohammadnejad; Shahab Faghihi Tel +9821 8609-3078Tel/ Fax +98 21 44787386Fax +98(21)88497324Email mohamadnejad@ut.ac.ir; sfaghihi@nigeb.ac.irBackground: Ineffective integration has been recognized as one of the major causes of early orthopedic failure of titanium-based implants. One strategy to address this problem is to develop modified titanium surfaces that promote osteoblast differentiation. This study explored titanium surfaces modified with TiO2 nanotubes (TiO2 NTs) capable of localized drug delivery into bone and enhanced osteoblast cell differentiation.Materials and Methods: Briefly, TiO2 NTs were subjected to anodic oxidation and loaded with Metformin, a widely used diabetes drug. To create surfaces with sustainable drug-eluting characteristics, TiO2 NTs were spin coated with a thin layer of chitosan. The surfaces were characterized via scanning electron microscopy, atomic force microscopy, and contact angle measurements. The surfaces were then exposed to mesenchymal bone marrow stem cells (MSCs) to evaluate cell adhesion, growth, differentiation, and morphology on the modified surfaces.Results: A noticeable increase in drug release time (3 days vs 20 days) and a decrease in burst release characteristics (85% to 7%) was observed in coated samples as compared to uncoated samples, respectively. Chitosan-coated TiO2 NTs exhibited a considerable enhancement in cell adhesion, proliferation, and genetic expression of type I collagen, and alkaline phosphatase activity as compared to uncoated TiO2 NTs.Conclusion: TiO2 NT surfaces with a chitosan coating are capable of delivering Metformin to a bone site over a sustained period of time with the potential to enhance MSCs cell attachment, proliferation, and differentiation.Keywords: titania nanotubes, titanium, osteogenic differentiation, anodization, mesenchymal bone marrow stem cells, MSCs
format article
author Hashemi A
Ezati M
Mohammadnejad J
Houshmand B
Faghihi S
author_facet Hashemi A
Ezati M
Mohammadnejad J
Houshmand B
Faghihi S
author_sort Hashemi A
title Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation
title_short Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation
title_full Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation
title_fullStr Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation
title_full_unstemmed Chitosan Coating of TiO2 Nanotube Arrays for Improved Metformin Release and Osteoblast Differentiation
title_sort chitosan coating of tio2 nanotube arrays for improved metformin release and osteoblast differentiation
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/c1a348c3c616449e98713e4d19817aee
work_keys_str_mv AT hashemia chitosancoatingoftio2nanotubearraysforimprovedmetforminreleaseandosteoblastdifferentiation
AT ezatim chitosancoatingoftio2nanotubearraysforimprovedmetforminreleaseandosteoblastdifferentiation
AT mohammadnejadj chitosancoatingoftio2nanotubearraysforimprovedmetforminreleaseandosteoblastdifferentiation
AT houshmandb chitosancoatingoftio2nanotubearraysforimprovedmetforminreleaseandosteoblastdifferentiation
AT faghihis chitosancoatingoftio2nanotubearraysforimprovedmetforminreleaseandosteoblastdifferentiation
_version_ 1718394832546693120